Mark Wilkinson
Co-founder and Chief Scientific Officer at Bactobio
London, United Kingdom
Summary
Scientific entrepreneur focused on discovering novel antimicrobials from uncultured microbes. bacto+1
Academic researcher with expertise in synthetic biology and biosynthetic platforms, having developed bacterial production and screening approaches for natural-product derivatives aimed at antimalarial drug discovery. biorxiv+1
Cross-sector experience bridging academia and industry through placements and fellowships (GSK placement, RAEng enterprise membership), reflecting a track record of translation and collaboration. ac+1
Operational and fundraising contributor in a growing biotech: involved in team growth, lab build-outs, and supporting multiple funding rounds to scale Bactobio's discovery pipeline. microbiologysociety+1